Búsqueda | Biblioteca Virtual en Salud

1.

The androgen cytosol receptor in the ventral prostate of the rat. Methodological problems.

HØisaeter, P A.

Biochim Biophys Acta ; 317(2): 492-9, 1973 Aug 30.

Artículo en Inglés | MEDLINE | ID: mdl-19999731

2.

Renal malignancies: outcome of patients in stage 4 with or without embolization procedure.

Bakke, A; Goethlin, J; Høisaeter, P A.

Urology ; 26(6): 541-3, 1985 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-4071864

3.

Phase II studies on prostate cancer.

Schröder, F H; Norming, U; Blumenstein, B A; Busch, C; Van Glabbeke, M; Høisaeter, P A; Johansson, J E; Tribukait, B.

Urology ; 49(4A Suppl): 3-14, 1997 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-9111610

4.

Staging of early prostate cancer: a proposed tumor volume-based prognostic index.

Bostwick, D G; Graham, S D; Napalkov, P; Abrahamsson, P A; di Sant'agnese, P A; Algaba, F; Hoisaeter, P A; Lee, F; Littrup, P; Mostofi, F K.

Urology ; 41(5): 403-11, 1993 May.

Artículo en Inglés | MEDLINE | ID: mdl-8488608

5.

Expression of p 16 protein in prostatic adenocarcinomas, intraepithelial neoplasia, and benign/hyperplastic glands.

Halvorsen, O J; Haukaas, S; Høisæter, P Å; Akslen, L A.

Urol Oncol ; 3(2): 59-66, 1997.

Artículo en Inglés | MEDLINE | ID: mdl-21227061

6.

Estramustine binding in rat, baboon and human prostate measured by high pressure liquid chromatography.

Kirdani, R Y; Corrales, J J; Høisaeter, P A; Karr, J P; Murphy, G P; Sandberg, A A.

Steroids ; 37(5): 471-84, 1981 May.

Artículo en Inglés | MEDLINE | ID: mdl-7256814

7.

Independent prognostic importance of microvessel density in clinically localized prostate cancer.

Halvorsen, O J; Haukaas, S; Høisaeter, P A; Akslen, L A.

Anticancer Res ; 20(5C): 3791-9, 2000.

Artículo en Inglés | MEDLINE | ID: mdl-11268456

8.

Maximum Ki-67 staining in prostate cancer provides independent prognostic information after radical prostatectomy.

Halvorsen, O J; Haukaas, S; Høisaeter, P A; Akslen, L A.

Anticancer Res ; 21(6A): 4071-6, 2001.

Artículo en Inglés | MEDLINE | ID: mdl-11911294

9.

Follow-up after torsion of the spermatic cord.

Daehlin, L; Ulstein, M; Thorsen, T; Høisaeter, P A.

Scand J Urol Nephrol Suppl ; 179: 139-42, 1996.

Artículo en Inglés | MEDLINE | ID: mdl-8908680

10.

Imaging in the diagnosis and assessment of prognosis in localized prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.

Høisaeter, P A; Norlén, B J; Norming, U; Ebert, T; Mattrey, R; Nilsson, S; Norberg, M; Pollack, H; Salo, J; Torp-Pedersen, S.

Scand J Urol Nephrol Suppl ; 162: 89-106; discussion 115-27, 1994.

Artículo en Inglés | MEDLINE | ID: mdl-7529431

11.

Estramustine phosphate (Estracyt): experimental and clinical studies in Europe.

Hoisaeter, P A; Bakke, A.

Semin Oncol ; 10(3 Suppl 3): 27-33, 1983 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-6364363

12.

Mode of action of Emcyt.

Høisaeter, P A.

Urology ; 23(6 Suppl): 46-8, 1984 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-6375079

13.

The Scandinavian Prostatic Cancer Group.

Høisaeter, P A; Rasmussen, F.

Scand J Clin Lab Invest Suppl ; 179: 7-11, 1985.

Artículo en Inglés | MEDLINE | ID: mdl-2934797

14.

Radical surgery in prostatic cancer.

Høisaeter, P A.

Nihon Hinyokika Gakkai Zasshi ; 83(6): 798-9, 1992 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-1501381

15.

Carcinoma of the prostate. Treatment philosophy in cancer of the prostate--primary treatment.

Høisaeter, P A.

Scand J Urol Nephrol Suppl ; 139: 47-52, 1991.

Artículo en Inglés | MEDLINE | ID: mdl-1767273

16.

An institutional experience in handling intracapsularly located prostate cancer.

Høisaeter, P A.

Scand J Urol Nephrol Suppl ; 138: 105-7, 1991.

Artículo en Inglés | MEDLINE | ID: mdl-1784991

17.

Effect of a steroidal alkylating agent (estramustine phosphate) in rat ventral prostate.

Høisaeter, P A.

Scand J Urol Nephrol Suppl ; (46): 1-72, 1977.

Artículo en Inglés | MEDLINE | ID: mdl-279091

18.

Clean intermittent catheterization in lower urinary tract dysfunction--an overview.

Bakke, A; Høisaeter, P A.

Scand J Urol Nephrol Suppl ; 157: 55-60, 1994.

Artículo en Inglés | MEDLINE | ID: mdl-7939454

19.

Incorporation of 3H-thymidine and 14C-amino acids into the ventral prostate after in vivo treatment with estradiol-3N-BIS(2-chloroethyl)carbamate-17 beta-phosphate (Estracyt) and its estrogen and cytostatic parts.

Hoisaeter, P A.

Invest Urol ; 14(2): 85-92, 1976 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-972011

20.

The effect of oestradiol-3N-bis-(2-chloroethyl)carbamate-17beta-phosphate (estracyt) on the 5alpha-reductase in the rat ventral prostate.

Hoisaeter, P A.

Acta Endocrinol (Copenh) ; 80(1): 188-98, 1975 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-1173982

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

The androgen cytosol receptor in the ventral prostate of the rat. Methodological problems.

Renal malignancies: outcome of patients in stage 4 with or without embolization procedure.

Phase II studies on prostate cancer.

Staging of early prostate cancer: a proposed tumor volume-based prognostic index.

Expression of p 16 protein in prostatic adenocarcinomas, intraepithelial neoplasia, and benign/hyperplastic glands.

Estramustine binding in rat, baboon and human prostate measured by high pressure liquid chromatography.

Independent prognostic importance of microvessel density in clinically localized prostate cancer.

Maximum Ki-67 staining in prostate cancer provides independent prognostic information after radical prostatectomy.

Follow-up after torsion of the spermatic cord.

Imaging in the diagnosis and assessment of prognosis in localized prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.

Estramustine phosphate (Estracyt): experimental and clinical studies in Europe.

Mode of action of Emcyt.

The Scandinavian Prostatic Cancer Group.

Radical surgery in prostatic cancer.

Carcinoma of the prostate. Treatment philosophy in cancer of the prostate--primary treatment.

An institutional experience in handling intracapsularly located prostate cancer.

Effect of a steroidal alkylating agent (estramustine phosphate) in rat ventral prostate.

Clean intermittent catheterization in lower urinary tract dysfunction--an overview.

Incorporation of 3H-thymidine and 14C-amino acids into the ventral prostate after in vivo treatment with estradiol-3N-BIS(2-chloroethyl)carbamate-17 beta-phosphate (Estracyt) and its estrogen and cytostatic parts.

The effect of oestradiol-3N-bis-(2-chloroethyl)carbamate-17beta-phosphate (estracyt) on the 5alpha-reductase in the rat ventral prostate.